Track topics on Twitter Track topics that are important to you
The U.S. Food and Drug Administration approved Gilead Sciences' drug Descovy to reduce the risk of sexually acquired HIV infection in adults and adolescents who do not have HIV, but are exposed to risk. This is the second drug to be approved by the FDA to prevent HIV infection as part of its efforts to end the epidemic. However, Descovy yet indicated for certain groups, including use by women.
Original Article: FDA Approves Descovy, Second Drug To Prevent HIV InfectionNEXT ARTICLE
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...
AIDS and HIV
AIDS; Acquired Immune Deficiency Syndrome. HIV; Human Immunodeficiency Virus HIV infection causes AIDS. HIV infection also causes the production of anti-HIV antibodies, which forms the test for HIV in patients. People who have the HIV antibodies are ...